These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28033029)

  • 21. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease.
    Galt SW; McDaniel MD; Ault KA; Mitchell J; Cronenwett JL
    J Vasc Surg; 1991 Dec; 14(6):747-55; discussion 755-6. PubMed ID: 1720468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative platelet and monocyte activation in patients with critical limb ischemia.
    Burdess A; Nimmo AF; Campbell N; Harding SA; Garden OJ; Dawson AR; Newby DE
    J Vasc Surg; 2010 Sep; 52(3):697-703. PubMed ID: 20816321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis.
    Gremmel T; Ay C; Riedl J; Kopp CW; Eichelberger B; Koppensteiner R; Panzer S
    Thromb Haemost; 2016 Mar; 115(3):615-21. PubMed ID: 26467184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
    Riba R; Nicolaou A; Troxler M; Homer-Vaniasinkam S; Naseem KM
    Atherosclerosis; 2004 Jul; 175(1):69-75. PubMed ID: 15186948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets.
    Bunescu A; Seideman P; Lenkei R; Levin K; Egberg N
    J Rheumatol; 2004 Dec; 31(12):2347-55. PubMed ID: 15570633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
    Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is enhanced platelet activation the missing link leading to increased cardiovascular risk in psoriasis?
    Chandrashekar L; Rajappa M; Revathy G; Sundar I; Munisamy M; Ananthanarayanan PH; Thappa DM; Basu D
    Clin Chim Acta; 2015 Jun; 446():181-5. PubMed ID: 25920693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet dysfunction contributes to bleeding complications in patients with probable leptospirosis.
    Tunjungputri RN; Gasem MH; van der Does W; Sasongko PH; Isbandrio B; Urbanus RT; de Groot PG; van der Ven A; de Mast Q
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005915. PubMed ID: 28934202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is thrombocytopenia suggestive of organism-specific response in neonatal sepsis?
    Manzoni P; Mostert M; Galletto P; Gastaldo L; Gallo E; Agriesti G; Farina D
    Pediatr Int; 2009 Apr; 51(2):206-10. PubMed ID: 19405917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRP/CD11b ratio: a novel parameter for detecting gram-positive sepsis.
    Nuutila J; Jalava-Karvinen P; Hohenthal U; Laitinen I; Kotilainen P; Rajamäki A; Nikoskelainen J; Lilius EM
    Hum Immunol; 2009 Apr; 70(4):237-43. PubMed ID: 19480860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin.
    Nakamura T; Ebihara I; Shoji H; Ushiyama C; Suzuki S; Koide H
    Inflamm Res; 1999 Apr; 48(4):171-5. PubMed ID: 10344466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased platelet activity in patients with isolated coronary artery ectasia.
    Yasar AS; Erbay AR; Ayaz S; Turhan H; Metin F; Ilkay E; Sabah I
    Coron Artery Dis; 2007 Sep; 18(6):451-4. PubMed ID: 17700216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelets from children are hyper-responsive to activation by thrombin receptor activator peptide and adenosine diphosphate compared to platelets from adults.
    Yip C; Linden MD; Attard C; Monagle P; Ignjatovic V
    Br J Haematol; 2015 Feb; 168(4):526-32. PubMed ID: 25266817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous assay of activated platelet count and platelet-activating capacity by P-selectin detection using K2-EDTA-treated whole blood for antiplatelet agents.
    Okano K; Araki M; Mimura Y; Nogaki H; Ichihara K
    Int J Lab Hematol; 2012 Dec; 34(6):621-9. PubMed ID: 22862794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased platelet reactivity in idiopathic pulmonary fibrosis is mediated by a plasma factor.
    Crooks MG; Fahim A; Naseem KM; Morice AH; Hart SP
    PLoS One; 2014; 9(10):e111347. PubMed ID: 25338090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.
    Rajagopalan S; Mckay I; Ford I; Bachoo P; Greaves M; Brittenden J
    J Vasc Surg; 2007 Sep; 46(3):485-90. PubMed ID: 17826235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphodiesterase 3 inhibition reduces platelet activation and monocyte tissue factor expression in knee arthroplasty patients.
    Beppu S; Nakajima Y; Shibasaki M; Kageyama K; Mizobe T; Shime N; Matsuda N
    Anesthesiology; 2009 Dec; 111(6):1227-37. PubMed ID: 19934866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.